BLOG

biospace

From Zero to Hero: Biopharma’s Pivotal Inflection Point

As Glenn Mattes, CEO of TFF Pharmaceuticals, told BioSpace, “The persistent rise of COVID-19 cases, including among the vaccinated, has understandably impacted the morale of both the biopharma industry and the broader community.”